Signal active
Organization
Contact Information
Overview
Infermedica, a leading digital health company, tackles the problem of inappropriate use of medical services and misdiagnosis, providing insurance companies, hospitals, and health systems with a set of AI-powered preliminary diagnosis and triage solutions.
“The broader goal is to improve customers’ performance, increase healthcare accessibility, and reduce costs. To date, our tools have been used by over 6 million users worldwide, and we are working with more than 50 companies, including Allianz Worldwide Partners, Microsoft, Global Excel, Médis, PZU Zdrowie, Sana Kliniken or Everyday Health,” says Piotr Orzechowski, Infermedica’s CEO.
The company uses artificial intelligence and machine learning to assess symptoms and find patterns in data. Thanks to algorithms, Infermedica gets smarter over time. Additionally, the team of physicians verifies every piece of information that is added to the medical database to ensure that patients get safe and reliable recommendations. To date, physicians involved in the project have spent over 30,000 hours on reviews.
Over the last year, Infermedica grew into a team of over 100 people, and its products were translated into 17 languages, making them available in countries such as China and the United Arab Emirates. The latest investment round of $10.25M will help to expand market presence in the United States and Europe, and accelerate the development of the technology.
About
Artificial Intelligence (AI), Machine Learning, Predictive Analytics, Health Care, mHealth, Personal Health, Hospital, Health Insurance
2012
101-250
Headquarters locations
Wroclaw, Dolnoslaskie, Poland, Europe
Social
Profile Resume
Infermedica headquartered in Europe, operates in the Artificial Intelligence (AI), Machine Learning, Predictive Analytics, Health Care, mHealth, Personal Health, Hospital, Health Insurance sector. The company focuses on Artificial Intelligence (AI) and has secured $15.8B in funding across 352 round(s). With a team of 101-250 employees, Infermedica is actively contributing to advancements in Artificial Intelligence (AI). Their latest funding round, Seed Round - Infermedica, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
11
1
0
$45.0M
Details
7
Infermedica has raised a total of $45.0M in funding over 7 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2022 | Early Stage Venture | 30.0M | ||
2016 | Seed | |||
2012 | Seed | |||
2013 | Seed |
Investors
Infermedica is funded by 40 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Infermedica | - | FUNDING ROUND - Infermedica | undefined |
Unfold.vc | - | FUNDING ROUND - Unfold.vc | undefined |
Infermedica | - | FUNDING ROUND - Infermedica | undefined |
Innovation Nest | - | FUNDING ROUND - Innovation Nest | undefined |
Recent Activity
News
Jun 01, 2024
openPR.com - Future-Proofing Growth of Smart Pre-Consultation Solutions
News
May 22, 2024
PharmiWeb.com - Revolutionizing Patient Care: Healthcare Chatbots Market to Grow at 20.1% CAGR | Market.us
News
May 05, 2024
openPR.com - Future-Proofing Growth of Virtual Medical Triage Platforms
News
May 05, 2024
Forbes - How Virtual Triage Impacts Patient Behavior
News
May 03, 2024
Healthcare IT News - Telemedicine, enabled with responsible AI, can improve the patient experience
News
May 03, 2024
Forbes - How Virtual Triage Impacts Patient Behavior